Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

Overview of attention for article published in Patient preference and adherence, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 1 news story.

Treatment with turoctocog alfa pegol (Esperoct, Novo Nordisk) stabilized or improved health-related quality of life (HRQoL) in…